Comparison

QS/1 DeliveryRx vs CareLink SmartSync™ US

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

QS/1 DeliveryRx

This app enables efficient prescription delivery for pharmacies, functioning offline to capture signatures and payments. It streamlines the delivery process, allowing multiple stores to be managed on a single device and syncing data via Wi-Fi.

Highlights
  • Offline transaction management
  • Signature capture (HIPAA, controlled substance)
  • Cash and check payment acceptance
  • Multi-store delivery on one device
  • Driver/delivery person assignment
  • Delivery notes and charge amounts
Features
Read full description

QS/1’s DeliveryRx is a prescription delivery application for iPads that does not require an Internet connection or cell phone signal at the point-of-delivery. DeliveryRx is an off-line app that downloads transactions, captures signatures, accepts cash or checks at the point-of-delivery and allows deliveries for multiple stores on the same device. Completed transactions can be uploaded to QS/1 Pharmacy Management Systems via the pharmacy’s Wi-Fi. DeliveryRx features include, the ability to download transactions directly to the device; capture required signatures (HIPAA, controlled substance, etc.); accept cash or check payments; assign a driver/delivery person to each device; add charge amounts for each delivery and display driver/delivery notes. DeliveryRx streamlines the delivery process while increasing productivity and ensuring QS/1 Customers have the tools needed to remain competitive in an evolving healthcare environment. Disclaimer: This app uses GPS to determine your location for the map function. Continued use of GPS running in the background can dramatically decrease battery life.

About

CareLink SmartSync™ US

This application allows clinicians to remotely program and manage implantable medical devices. It provides access to device settings, pacing system analysis, and data reporting tools for use in clinical settings.

Highlights
  • Bluetooth connectivity
  • Tablet connectivity tools
  • Data export
  • App software updates
  • Pacing system analysis
  • Implantable device programming
Read full description

The portable Medtronic CareLink SmartSync™ Device Manager allows clinicians to make programming changes to implantable devices in the operating suite or follow up clinic. The CareLink SmartSync™ Device Manager includes the CareLink SmartSync™ device manager app, CareLink SmartSync™ PSA app (pacing system analyzer), patient connector, base, and an Apple iPad®.* The device manager app is the primary interface of the device manager. The device manager app provides access to the implantable device apps and to the CareLink SmartSync PSA (Pacing System Analyzer) Application. This application includes the following features: • Bluetooth®* connectivity to communicate with the base and patient connector1 • Tablet connectivity tools for sharing and printing reports • Ability to export data • Ability to update the device manager app software using an Internet connection • Access to the CareLink SmartSync PSA (Pacing System Analyzer) application (referred to as the analyzer) to assess the pacing and sensing performance of the cardiac lead system during the implant of an implantable cardiac device • Access to implantable device apps, which communicate with implantable devices and allow the user to program the implantable device settings and view stored implanted device data The device manager is intended for use by healthcare professionals or Medtronic representatives in a clinical or hospital environment. * For tablet specifications, please consult www.medtronic.com/manuals. † For device compatibility, please consult www.medtronic.com/manuals.

Verdict

The call

The clearest difference is review sentiment: CareLink SmartSync™ US at 50% against QS/1 DeliveryRx's 0%. QS/1 DeliveryRx's advantage is iOS requirement (8.2 vs 17.0). On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

QS/1 DeliveryRx ships an update every 3 months, CareLink SmartSync™ US every 4 months. The most recent releases landed on November 13, 2026 and November 15, 2026 respectively.

Scorecard2 real differences · 8 level
QS/1 DeliveryRx versus CareLink SmartSync™ US: the parameters behind the verdict, then further details
ParameterQS/1 DeliveryRxCareLink SmartSync™ US
PriceFreeFree
Rating—3.8 (16 ratings) — better
Positive reviews0.0% of reviews50.0% of reviews — better
Number of ratings—16 — better
Update frequencyEvery 3 months — betterEvery 4 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPadiPad
Requires iOS8.2 — better17.0
Further details — not scored
Size55 MB304 MB
Age rating17+17+
DeveloperRedSail Technologies, LLCMedtronic, Inc.

Customer experience

QS/1 DeliveryRx

Written reviews1 reviews
Positive0.0%
Neutral100.0%
Negative0.0%

CareLink SmartSync™ US

All ratings16 ratings
Positive68.8%
Neutral0.0%
Negative31.3%
Written reviews4 reviews
Positive50.0%
Neutral0.0%
Negative50.0%

In-app purchases

None

QS/1 DeliveryRx

No in-app purchases

None

CareLink SmartSync™ US

No in-app purchases

Questions

Is QS/1 DeliveryRx free?
QS/1 DeliveryRx is free to download, with no in-app purchases.
Is CareLink SmartSync™ US free?
CareLink SmartSync™ US is free to download, with no in-app purchases.
Do QS/1 DeliveryRx or CareLink SmartSync™ US have ads?
Neither QS/1 DeliveryRx nor CareLink SmartSync™ US shows ads.
Which is updated more often, QS/1 DeliveryRx or CareLink SmartSync™ US?
QS/1 DeliveryRx ships an update every 3 months, and CareLink SmartSync™ US every 4 months. Most recently, QS/1 DeliveryRx was updated on November 13, 2026 and CareLink SmartSync™ US on November 15, 2026.

Other comparisons